Volume 148, Issue 1, Pages 100-107.e1 (January 2015) Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study Michael P. Curry, Xavier Forns, Raymond T. Chung, Norah A. Terrault, Robert Brown, Jonathan M. Fenkel, Fredric Gordon, Jacqueline O’Leary, Alexander Kuo, Thomas Schiano, Gregory Everson, Eugene Schiff, Alex Befeler, Edward Gane, Sammy Saab, John G. McHutchison, G. Mani Subramanian, William T. Symonds, Jill Denning, Lindsay McNair, Sarah Arterburn, Evguenia Svarovskaia, Dilip Moonka, Nezam Afdhal Gastroenterology Volume 148, Issue 1, Pages 100-107.e1 (January 2015) DOI: 10.1053/j.gastro.2014.09.023 Copyright © 2015 AGA Institute Terms and Conditions
Figure 1 No recurrence/recurrence by days HCV RNA continuously target not detected before liver transplantation. TND, Target not detected. Gastroenterology 2015 148, 100-107.e1DOI: (10.1053/j.gastro.2014.09.023) Copyright © 2015 AGA Institute Terms and Conditions
Supplementary Figure 1 Patient disposition. Gastroenterology 2015 148, 100-107.e1DOI: (10.1053/j.gastro.2014.09.023) Copyright © 2015 AGA Institute Terms and Conditions